FAQs

Where is Anpac Bio’s corporate headquarters?

801 Bixing Street, Bihu County
Lishui, Zhejiang Province 323006
People’s Republic of China
+86-578-2051-666

Where was the company incorporated?

British Virgin Islands

When did Anpac Bio go public?

AnPac Bio became a publicly listed company in January 2020

What is Anpac Bio’s fiscal year?

January 1 – December 31

How is Anpac Bio stock traded?

AnPac Bio’s ADSs trade on the NASDAQ Global Market under the ticker “ANPC”

Who is Anpac Bio’s transfer agent?

Citibank, N.A.

Who is Anpac Bio’s auditor?

Friedman LLP

Who is Anpac Bio’s legal counsel?

Kaufman & Canoles, PC

Where can I get the latest annual reports?

Annual reports will be available via this website. All SEC documents are also accessible online through the SEC Filings page.

How can I obtain further information or materials on Anpac Bio?

You can submit your inquiry to our investor relations team through the Contact Us page.

How can I receive email updates for earnings release information?

Please sign up for E-mail Alerts here

Whom should I contact regarding investor inquiries?

For investor and media inquiries, please contact:

AnPac Bio-Medical Science Co., Ltd.
E-mail: [email protected]

Ascent Investor Relations LLC
Tina Xiao, President
Phone: +1-917-609-0333 (US)
Email: [email protected]

Quick Links

Contact Information

Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002

Email: [email protected]

Phone Number: +1 (267) 810-6776

Anpac Bio-Medical Science Co., Ltd.

Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.